Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

29.59 -1.33 (-4.30%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 836,772
Open 30.50
Bid (Size) 29.70 (1)
Ask (Size) 30.10 (1)
Prev. Close 30.92
Today's Range 29.40 - 30.92
52wk Range 13.84 - 62.49
Shares Outstanding 40,068,890
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Big Reasons to Sell Cassava Sciences Stock Right Now
It isn't about running out of money, but it's still laden with risk. 
Via The Motley Fool
If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today
 
Via Benzinga

Performance

YTD
+6.59%
+6.59%
1 Month
+2.67%
+2.67%
3 Month
-13.25%
-13.25%
6 Month
+52.37%
+52.37%
1 Year
-37.10%
-37.10%

More News

Read More
Cassava Sciences Stock Undervalued with Its $124 Price Target?
Via MarketBeat
Exposures Product Safety
Tesla, Amazon, Microsoft, Cassava Sciences, Intuitive Surgical: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Why Is Cassava Sciences (SAVA) Stock Down 20% Today?
Via InvestorPlace
$100 Invested In Cassava Sciences 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Why Is Cassava Sciences (SAVA) Stock Up 10% Today?
Via InvestorPlace
Cassava Sciences Stock Is Diving: What's Going On?
Via Benzinga
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Cassava Sciences Shares Fall As Alzheimer's Candidate Worsens Patients With Moderate Disease
Via Benzinga
Cassava Plummets As 'Highly Desirable' Alzheimer's Results Don't Cut It With Investors
Via Investor's Business Daily
3M, Magna International And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
Via Benzinga
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
From Cassava Sciences, Inc.
Via Globe NewsWire
Is a Short Squeeze Coming in Cassava Sciences (SAVA) Stock?
Via InvestorPlace
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish
Via Talk Markets
SAVA, LLY, IBB: Why These Alzheimer's Related Stocks Are Volatile On Friday
Via Benzinga
Cassava Sciences Mourns the Death of Board Member and Officer Nadav Friedmann, PhD, MD
From Cassava Sciences, Inc.
Via Globe NewsWire
Is Anavex Life Sciences a Buy?
Via The Motley Fool
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Cassava Sciences Announces Completion of Dosing in Open-label Study of Simufilam for Alzheimer’s Disease
From Cassava Sciences, Inc.
Via Globe NewsWire
Cassava Sciences Announces Closing of $50 Million Registered Direct Offering
From Cassava Sciences, Inc.
Via Globe NewsWire
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
From Cassava Sciences, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.